Catalina Capital Group LLC Has $325,000 Stock Holdings in UnitedHealth Group Incorporated $UNH

Catalina Capital Group LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 40.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,042 shares of the healthcare conglomerate’s stock after selling 713 shares during the quarter. Catalina Capital Group LLC’s holdings in UnitedHealth Group were worth $325,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of UNH. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Apella Capital LLC raised its stake in shares of UnitedHealth Group by 44.1% during the 1st quarter. Apella Capital LLC now owns 1,682 shares of the healthcare conglomerate’s stock worth $973,000 after purchasing an additional 515 shares in the last quarter. Nixon Peabody Trust Co. raised its stake in shares of UnitedHealth Group by 34.0% during the 1st quarter. Nixon Peabody Trust Co. now owns 536 shares of the healthcare conglomerate’s stock worth $281,000 after purchasing an additional 136 shares in the last quarter. Finally, Johnson & White Wealth Management LLC raised its stake in shares of UnitedHealth Group by 1.5% during the 1st quarter. Johnson & White Wealth Management LLC now owns 1,798 shares of the healthcare conglomerate’s stock worth $942,000 after purchasing an additional 26 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.4%

UNH stock opened at $353.26 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $319.94 billion, a price-to-earnings ratio of 15.31, a PEG ratio of 2.27 and a beta of 0.47. The business’s fifty day moving average price is $306.25 and its two-hundred day moving average price is $356.57. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business earned $6.80 EPS. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Wells Fargo & Company dropped their price target on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Morgan Stanley increased their price target on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Royal Bank Of Canada dropped their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Finally, JPMorgan Chase & Co. dropped their price target on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.